A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
We performed a one-point, lipophilic cell-tracer injection to track endothelial cells, followed by an arteriotomy and suturing of sidewall aneurysms on the abdominal rat aorta. Neointima formation seemed dependent on the parent artery in decellularized aneurysms and was promoted by the recruitment from aneurysm wall cells in vital cell-rich walls.
Microsurgical clipping creates a subsequent barrier of blood flow into intracranial aneurysms, whereas endovascular treatment relies on neointima and thrombus formation. The source of endothelial cells covering the endoluminal layer of the neointima remains unclear. Therefore, the aim of the present study was to investigate the origin of neointima-forming cells after cell-tracer injection in the already well-established Helsinki rat microsurgical sidewall aneurysm model.
Sidewall aneurysms were created by suturing decellularized or vital arterial pouches end-to-side to the aorta in male Lewis rats. Before arteriotomy with aneurysm suture, a cell-tracer injection containing CM-Dil dye was performed into the clamped aorta to label endothelial cells in the adjacent vessel and track their proliferation during follow-up (FU). Treatment followed by coiling (n = 16) or stenting (n = 15). At FU (7 days or 21 days), all rats underwent fluorescence angiography, followed by aneurysm harvesting and macroscopic and histological evaluation with immunohistological cell counts for specific regions of interest.
None of the 31 aneurysms had ruptured upon follow-up. Four animals died prematurely. Macroscopically residual perfusion was observed in 75.0% coiled and 7.0% of stented rats. The amount of cell-tracer-positive cells was significantly elevated in decellularized stented compared to coiled aneurysms with respect to thrombus on day 7 (p = 0.01) and neointima on day 21 (p = 0.04). No significant differences were found in thrombus or neointima in vital aneurysms.
These findings confirm worse healing patterns in coiled compared to stented aneurysms. Neointima formation seems particularly dependent on the parent artery in decellularized aneurysms, whereas it is supported by the recruitment from aneurysm wall cells in vital cell-rich walls. In terms of translation, stent treatment might be more appropriate for highly degenerated aneurysms, whereas coiling alone might be adequate for aneurysms with mostly healthy vessel walls.
Subarachnoid hemorrhage caused by the rupture of an intracranial aneurysm (IA) is a devastating neurosurgical condition associated with high morbidity and mortality1,2,3,4. In addition to microsurgical clipping, which provides direct endothelium-to-endothelium contact, endovascular devices have gained increasing importance over the past decades for treating ruptured and incidentally discovered IAs. The healing response in endovascularly treated IAs mainly depends on neointima formation and thrombus organization. Both are synergic processes, ....
Veterinary support was performed according to institutional guidelines. Experiments were approved by the Local Ethics Committee, Switzerland (BE 60/19). The ARRIVE guidelines and 3R principles have been strictly followed6,7. Thirty-one male Lewis rats, 12 weeks old and weighing 492 ± 8 g, were included. House all rats at a room temperature of 23 °C and a 12 h light/dark cycle. Provide free access to water and pellets. Statistical analyses have been.......
A total of 31 animals were included in the laboratory setting: 27 rats were included in the final statistical analysis; 4 rats died prematurely (12.9% mortality rate). Intraoperatively, breath distension was significantly (p = 0.03) reduced in stent- (12.9 μm ± 0.7) compared to coil-treated (13.5 μm ± 0.6) rats. Fluorescence angiography was performed for every rat at the end of the final FU. Reperfusion was indicated in all 6 coil-treated animals, whereas reperfusion was observed in only 12.5.......
This study demonstrates that neointima formation is mediated via endothelial cells originating in the parent artery of the aneurysm complex but is supported by the recruitment of cells derived from the aneurysm wall in vital aneurysms. Nevertheless, the role of circulating progenitor cells in aneurysm healing remains controversial12,13. Overall, 31 male Lewis rats were included in this investigation; only 4 died prematurely (12.9% mortality).
The authors thank Alessandra Bergadano, DVM, PhD, for the dedicated supervision of long-term animal health. This work was supported by the research funds of the Research Council, Kantonsspital Aarau, Aarau, Switzerland, and the Swiss national science foundation SNF (310030_182450).
....Name | Company | Catalog Number | Comments |
3-0 resorbable suture | Ethicon Inc., USA | VCP428G | |
4-0 non-absorbable suture | B. Braun, Germany | G0762563 | |
6-0 non-absorbable suture | B. Braun, Germany | C0766070 | |
9-0 non-absorbable suture | B. Braun, Germany | G1111140 | |
Atipamezol | Arovet AG, Switzerland | ||
Bandpass filter blue | Thorlabs | FD1B | any other |
Bandpass filter green | Thorlabs | FGV9 | any other |
Bipolar forceps | any other | ||
Bicycle spotlight | any other | ||
Board (20 x 10 cm) | any other | ||
Buprenorphine | Indivior, Switzerland | 1014197 | |
Camera | Sony NEX-5R, Sony, Tokyo, Japan | ||
Cannula (27-1/2 G) | any other | ||
Cell count software | Image-J version 1.52n, U.S. National Institutes of Health, Bethesda, Maryland, USA, https://imagej.nih.gov/ij/ | ||
CellTracker CM-Dil dye | ThermoFisher SCIENTIFIC, USA | C7000 | |
Coil-Device | Styker, Kalamazoo, MI, USA | 2 cm of Target 360 TM Ultra, 2-mm diameter | |
Desinfection | any other | ||
Eye-lubricant | any other | ||
Fentanyl | Sintetica, S.A., Switzerland | 98683 | any generic |
Flumazenil | Labatec-Pharma, Switerzland | ||
Fluoresceine | Curatis AG | 5030376 | any generic |
Fluorescence microscope | Olympus BX51, Hamburg, Germany; Cell Sens Dimension Imaging software v1.8 | ||
Foil mask | any other | ||
Glucose (5%) | any other | ||
Heating pad | Homeothermic Control Unit, Harvard, Edenbridge, England | any other | |
Isotonic sodium chloride solution (0.9%) | Fresenius KABI | 336769 | any generic |
Isoflurane | any generic | ||
Longuettes | any other | ||
Meloxicam | Boehringer Ingelheim | P7626406 | any generic |
Medetomidine | Virbac, Switzerland | QN05CM91 | |
Micro needle holder | any other | ||
Midazolam | Roche, Switzerland | ||
Monitoring-system | Starr Life Sciences Corp., 333 Allegheny Ave, Oakmont, PA 15139, United States | ||
Needle holder | any other | ||
O2-Face mask | any other | ||
Operation microscope | OPMI, Carl Zeiss AG, Oberkochen, Germany | any other | |
Oxygen | any other | ||
Rectal temperature probe | any other | ||
Scalpell | Swann-Morton | 210 | any other |
Small animal shaver | any other | ||
Smartphone | any other | ||
Sodium dodecyl sulfate (0.1%) | Sigma-Aldrich | 11667289001 | |
Soft feed | Emeraid Omnivore | any generic | |
Soft tissue forceps | any other | ||
Soft tissue spreader | any other | ||
Stainless steel sponge bowls | any other | ||
Stent-Device | Biotroni, Bülach, Switzerland | modified magmaris device, AMS with polymer coating, 6-mm length, 2-mm diameter | |
Sterile micro swabs | any other | ||
Straight and curved microforceps | any other | ||
Straight and curved microscissors | any other | ||
Straight and curved forceps | any other | ||
Surgery drape | any other | ||
Surgical scissors | any other | ||
Syringes 1 mL, 2 mL, and 5 mL | any other | ||
Tape | any other | ||
Vascular clip applicator | B. Braun, Germany | FT495T | |
Yasargil titan standard clip (2x) | B. Braun Medical AG, Aesculap, Switzerland | FT242T | temporary |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved